START Shanghai
South Texas Accelerated Research Therapeutics (START) directs clinical trials of novel anticancer agents using a high quality and innovative information technology infrastructure to ensure accurate and rapid clinical trials in a setting that emphasizes personalized and compassionate clinical care. START’s head office is located in San Antonio, Texas, in the heart of the South Texas Medical Center.
With centers located in San Antonio, Texas and Madrid, Spain, START conducts the world’s largest Phase I medical oncology program – putting more than 500 patients per year on Phase I trials. Patients travel from all over the world to participate in one or more of our Phase I drug trials.
START consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research and are nationally recognized as thought leaders in cancer research and drug development.
The mission of START is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer. Our drug development program is not only furthering cancer research, but also offers hope to patients facing the toughest cancer battles.
To accomplish this mission START Shanghai will conduct high quality early Phase I and II studies to evaluate the safety, the recommended dose, and early evaluation of antitumor activity of new anticancer agents derived from large and mid size multi-national and Chinese domestic pharmaceutical companies, as well as small and medium size innovative biotechnology companies.
START Shanghai is part of fully integrated START Network of clinical sites in San Antonio (USA), Madrid (Spain) that provide sponsors with clinical data derived from clinical operations with uniform standard operating procedures (SOP), electronic data management and electronic data transfer. We are privileged that we could offer our help to the collaborations among the clinical physicians, the cancer patients and the new medicine developers in China.
Please visit our global website at http://www.startthecure.com
始达(上海)医药科技有限公司
START 全球的总部位于美国德克萨斯州的圣安东尼奥市。它是一家专注于肿瘤早期研究药物的创新开发和临床研究的公司。公司前身是美国德克萨斯州大学下属的抗癌药物研究所，为美国国家卫生院和癌症研究所，及制药企业进行了多年的临床试验工作。自2007年初开始成为一家独立运营的一期研究中心，并于2008年开设了西班牙的马德里分公司。START的高效运营得益于其完善的标准操作流程规范，和创新性地运用信息技术和电脑系统管理临床试验的全过程。START是世界上最大的一期肿瘤研究中心，每年有超过500例的新病人，有些病人甚至从世界各地专程来START参加临床试验。 START是由专业化极高的临床医生，和一期研究的辅助人员组成的研究团队，已成为新药创新的药厂和生物技术公司的可靠的合作伙伴和顾问。
START努力旨在加速新的抗癌药物的开发，从而提高癌症病人的存活期和生命质量。 我们的新药研究项目不仅可以促进抗肿瘤的研究，也可以为与癌症抗争的患者带来生命的希望。
始达医药肩负这一使命，在中国建立一个能承接高质量的早期研究平台，对创新的药物进行安全性，合适剂量及早期的抗癌活性的评估，为国际药厂，国内药厂，和不同的生物技术公司提供专业的研发服务。 始达医药作为START全球统一的研究网络中的一部分，与美国和欧洲的中心共同提供成熟的标准化的研究操作管理，电子数据信息化的管理和传输。 始达医药希望为中国的医生，癌症患者，和新药研发的公司的合作研究奉献我们绵薄之力。也会努力尽到我们的社会责任，目标成为国内该领域值得学习的标杆企业。
欢迎有志迎接新挑战、新机遇，有创业精神的医药研发人员加入始达医药，来帮助社会的同时实现自我价值的提升。
更多信息请浏览公司网站：http:// www.startthecure.com
请将中英文简历、一寸近照、身份证、学历等相关证书复印件寄至或传真至公司（请务必在信封和简历上注明应聘职位）
或在51job网站上直接发简历至本公司。
请您不要重复投递简历！
联 系 人：人力资源部
传真号码：(+86 21)61912359
地 址：上海市肇嘉浜路789号均瑶国际广场20楼E1-E2单元
邮政编码：200032
